• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本医护人员接种BNT162b2 mRNA新冠疫苗后3至6个月内SARS-CoV-2抗体滴度变化的相关因素:一项前瞻性研究

Factors Associated with Change in SARS-CoV-2 Antibody Titers from Three to Six Months after the Administration of the BNT162b2 mRNA COVID-19 Vaccine among Healthcare Workers in Japan: A Prospective Study.

作者信息

Mochizuki Takeshi, Hori Takaki, Yano Koichiro, Ikari Katsunori, Okazaki Ken

机构信息

Department of Rheumatology and Orthopedic Surgery, Kamagaya General Hospital, Japan.

Department of Cardiovascular Surgery, Kamagaya General Hospital, Japan.

出版信息

Intern Med. 2022 Apr 15;61(8):1139-1143. doi: 10.2169/internalmedicine.8902-21. Epub 2022 Feb 19.

DOI:10.2169/internalmedicine.8902-21
PMID:35185050
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9107982/
Abstract

Objective We evaluated the change in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody titers from three to six months after the administration of the BNT162b2 vaccine among healthcare workers. Methods A total of 337 healthcare workers who received 2 doses of the BNT162b2 vaccine were included in this study. Factors associated with SARS-CoV-2 antibody titers at three and six months and the change in SARS-CoV-2 antibody titers between three and six months after vaccine administration were analyzed using a logistic regression analysis. Results The SARS-CoV-2 antibody titer at 3 months was 4,812.1±3,762.9 AU/mL in all subjects and was lower in older workers than in younger ones. The SARS-CoV-2 antibody titer at 6 months was 1,368.9±1,412.3 AU/mL in all subjects. The SARS-CoV-2 antibody titers that were found to be high at three months were also high at six months. The change in SARS-CoV-2 antibody titers from 3 to 6 months was -68.9%±16.1%. The higher SARS-CoV-2 antibody titers at three months showed a more marked decrease from three to six months than lower titers. Conclusion This study demonstrates that SARS-CoV-2 antibody titers at three months decreased with age and were associated with the antibody titers at six months and the change in titer from three to six months. Older individuals in particular need to be aware of the declining SARS-CoV-2 antibody titers at six months after the BNT162b2 vaccine. The results of this study may provide insight into COVID-19 vaccine booster strategies.

摘要

目的 我们评估了医护人员接种BNT162b2疫苗后3至6个月严重急性呼吸综合征冠状病毒2(SARS-CoV-2)抗体滴度的变化。方法 本研究纳入了337名接种2剂BNT162b2疫苗的医护人员。采用逻辑回归分析方法分析了与接种疫苗后3个月和6个月时SARS-CoV-2抗体滴度相关的因素以及3至6个月期间SARS-CoV-2抗体滴度的变化。结果 所有受试者在3个月时的SARS-CoV-2抗体滴度为4812.1±3762.9 AU/mL,老年医护人员的抗体滴度低于年轻医护人员。所有受试者在6个月时的SARS-CoV-2抗体滴度为1368.9±1412.3 AU/mL。在3个月时抗体滴度高的受试者在6个月时抗体滴度也高。SARS-CoV-2抗体滴度从3个月到6个月的变化为-68.9%±16.1%。3个月时SARS-CoV-2抗体滴度越高,从3个月到6个月的下降幅度比低滴度者更明显。结论 本研究表明,3个月时的SARS-CoV-2抗体滴度随年龄增长而降低,并且与6个月时的抗体滴度以及3至6个月期间滴度的变化有关。特别是老年人需要注意在接种BNT162b2疫苗6个月后SARS-CoV-2抗体滴度的下降情况。本研究结果可能为2019冠状病毒病(COVID-19)疫苗加强策略提供见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9395/9107982/96769d3a43fb/1349-7235-61-1139-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9395/9107982/6068f1705410/1349-7235-61-1139-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9395/9107982/66db8cff15c8/1349-7235-61-1139-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9395/9107982/96769d3a43fb/1349-7235-61-1139-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9395/9107982/6068f1705410/1349-7235-61-1139-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9395/9107982/66db8cff15c8/1349-7235-61-1139-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9395/9107982/96769d3a43fb/1349-7235-61-1139-g003.jpg

相似文献

1
Factors Associated with Change in SARS-CoV-2 Antibody Titers from Three to Six Months after the Administration of the BNT162b2 mRNA COVID-19 Vaccine among Healthcare Workers in Japan: A Prospective Study.日本医护人员接种BNT162b2 mRNA新冠疫苗后3至6个月内SARS-CoV-2抗体滴度变化的相关因素:一项前瞻性研究
Intern Med. 2022 Apr 15;61(8):1139-1143. doi: 10.2169/internalmedicine.8902-21. Epub 2022 Feb 19.
2
Effect of the third dose of BNT162b2 vaccine on quantitative SARS-CoV-2 spike 1-2 IgG antibody titers in healthcare personnel.BNT162b2 疫苗第三剂对医护人员定量 SARS-CoV-2 刺突 1-2 IgG 抗体滴度的影响。
PLoS One. 2022 Mar 2;17(3):e0263942. doi: 10.1371/journal.pone.0263942. eCollection 2022.
3
Healthcare Workers in South Korea Maintain a SARS-CoV-2 Antibody Response Six Months After Receiving a Second Dose of the BNT162b2 mRNA Vaccine.韩国医护人员接种第二剂 BNT162b2 mRNA 疫苗 6 个月后仍保持对 SARS-CoV-2 的抗体应答。
Front Immunol. 2022 Jan 31;13:827306. doi: 10.3389/fimmu.2022.827306. eCollection 2022.
4
Association between history of HBV vaccine response and anti-SARS-CoV-2 spike antibody response to the BioNTech/Pfizer's BNT162b2 mRNA SARS-CoV-2 vaccine among healthcare workers in Japan: A prospective observational study.日本医护人员中乙型肝炎病毒疫苗反应史与对辉瑞/BioNTech 的 BNT162b2 mRNA 新冠疫苗刺突抗体反应的相关性:一项前瞻性观察性研究。
PLoS One. 2022 May 16;17(5):e0268529. doi: 10.1371/journal.pone.0268529. eCollection 2022.
5
Changes in SARS-CoV-2 Antibody Titers from Three to Nine Months after Administration of the BNT162b2 mRNA Vaccine among Healthcare Workers in Japan: A Prospective Study.日本医护人员接种BNT162b2 mRNA疫苗后3至9个月内新冠病毒抗体滴度的变化:一项前瞻性研究
Intern Med. 2022 Jul 1;61(13):2095. doi: 10.2169/internalmedicine.9695-22. Epub 2022 Apr 23.
6
Effect of the third dose of BNT162b2 COVID-19 mRNA vaccine on anti-SARS-CoV-2 antibody levels in healthcare workers.第三剂 BNT162b2 COVID-19 mRNA 疫苗对医护人员抗 SARS-CoV-2 抗体水平的影响。
Vaccine. 2023 Jan 9;41(2):365-371. doi: 10.1016/j.vaccine.2022.11.049. Epub 2022 Nov 24.
7
Immunological responses following the third dose of the BNT162b2 SARS-CoV-2 vaccine among Japanese healthcare workers.日本医护人员接种 BNT162b2 新冠疫苗第三针后的免疫应答。
J Infect Chemother. 2022 Nov;28(11):1478-1482. doi: 10.1016/j.jiac.2022.07.006. Epub 2022 Jul 31.
8
Young age, female sex, and presence of systemic adverse reactions are associated with high post-vaccination antibody titer after two doses of BNT162b2 mRNA SARS-CoV-2 vaccination: An observational study of 646 Japanese healthcare workers and university staff.在接受两剂 BNT162b2 mRNA SARS-CoV-2 疫苗接种后,年龄较小、女性、存在全身不良反应与高疫苗接种后抗体滴度相关:一项对 646 名日本医护人员和大学教职工的观察性研究。
Vaccine. 2022 Feb 11;40(7):1019-1025. doi: 10.1016/j.vaccine.2022.01.002. Epub 2022 Jan 7.
9
Dynamics of antibody titers and cellular immunity among Japanese healthcare workers during the 6 months after receiving two doses of BNT162b2 mRNA vaccine.接种两剂 BNT162b2 mRNA 疫苗 6 个月后日本医护人员的抗体效价和细胞免疫动力学。
Vaccine. 2022 Jul 30;40(32):4538-4543. doi: 10.1016/j.vaccine.2022.06.016. Epub 2022 Jun 17.
10
Antibody Responses to the BNT162b2 mRNA Vaccine in Healthcare Workers in a General Hospital in Japan: A Comparison of Two Assays for Anti-spike Protein Immunoglobulin G.在日本一家综合医院的医护人员中,BNT162b2 mRNA 疫苗的抗体反应:两种抗刺突蛋白免疫球蛋白 G 检测方法的比较。
Intern Med. 2022 Mar 15;61(6):811-819. doi: 10.2169/internalmedicine.8704-21. Epub 2021 Dec 28.

引用本文的文献

1
Long COVID in Healthcare Workers from a Pediatric Hospital in Romania: A Cross-Sectional Study of Prevalence, Symptom Burden, and the Role of Vaccination and Reinfection.罗马尼亚一家儿科医院医护人员的长期新冠症状:患病率、症状负担以及疫苗接种和再次感染作用的横断面研究
J Clin Med. 2025 Aug 15;14(16):5782. doi: 10.3390/jcm14165782.
2
Long-term antibody response after the third dose of inactivated SARS-CoV-2 vaccine in MASLD patients.MASLD 患者接种第三剂灭活 SARS-CoV-2 疫苗后的长期抗体反应。
BMC Gastroenterol. 2024 Sep 30;24(1):329. doi: 10.1186/s12876-024-03402-9.
3
Changes in SARS-CoV-2 antibody titers 6 months after the booster dose of BNT162b2 COVID-19 vaccine among health care workers.

本文引用的文献

1
Neutralizing antibody titers six months after Comirnaty vaccination: kinetics and comparison with SARS-CoV-2 immunoassays.Comirnaty 接种后六个月的中和抗体滴度:动力学和与 SARS-CoV-2 免疫测定的比较。
Clin Chem Lab Med. 2021 Dec 16;60(3):456-463. doi: 10.1515/cclm-2021-1247. Print 2022 Feb 23.
2
Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study.辉瑞-BioNTech 信使核糖核酸 COVID-19 疫苗在美国大型综合卫生系统中的 6 个月有效性:一项回顾性队列研究。
Lancet. 2021 Oct 16;398(10309):1407-1416. doi: 10.1016/S0140-6736(21)02183-8. Epub 2021 Oct 4.
3
医护人员接种BNT162b2新冠疫苗加强针6个月后SARS-CoV-2抗体滴度的变化。
Clin Exp Vaccine Res. 2023 Apr;12(2):116-120. doi: 10.7774/cevr.2023.12.2.116. Epub 2023 Apr 30.
4
The Four Ws of the Fourth Dose COVID-19 Vaccines: Why, Who, When and What.第四剂新冠疫苗的四个W:为何、何人、何时及何种。
Vaccines (Basel). 2022 Nov 14;10(11):1924. doi: 10.3390/vaccines10111924.
5
Association of Systemic Adverse Reactions and Serum SARS-CoV-2 Spike Protein Antibody Levels after Administration of BNT162b2 mRNA COVID-19 Vaccine.接种 BNT162b2 mRNA COVID-19 疫苗后全身不良反应与血清 SARS-CoV-2 刺突蛋白抗体水平的关系。
Intern Med. 2022 Nov 1;61(21):3205-3210. doi: 10.2169/internalmedicine.9699-22. Epub 2022 Aug 20.
6
Immunological responses following the third dose of the BNT162b2 SARS-CoV-2 vaccine among Japanese healthcare workers.日本医护人员接种 BNT162b2 新冠疫苗第三针后的免疫应答。
J Infect Chemother. 2022 Nov;28(11):1478-1482. doi: 10.1016/j.jiac.2022.07.006. Epub 2022 Jul 31.
7
Changes in SARS-CoV-2 Antibody Titers from Three to Nine Months after Administration of the BNT162b2 mRNA Vaccine among Healthcare Workers in Japan: A Prospective Study.日本医护人员接种BNT162b2 mRNA疫苗后3至9个月内新冠病毒抗体滴度的变化:一项前瞻性研究
Intern Med. 2022 Jul 1;61(13):2095. doi: 10.2169/internalmedicine.9695-22. Epub 2022 Apr 23.
Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months.
辉瑞-BioNTech 新冠疫苗接种 6 个月后免疫体液反应逐渐减弱。
N Engl J Med. 2021 Dec 9;385(24):e84. doi: 10.1056/NEJMoa2114583. Epub 2021 Oct 6.
4
Age and Smoking Predict Antibody Titres at 3 Months after the Second Dose of the BNT162b2 COVID-19 Vaccine.年龄和吸烟状况可预测第二次接种BNT162b2新冠疫苗3个月后的抗体滴度。
Vaccines (Basel). 2021 Sep 18;9(9):1042. doi: 10.3390/vaccines9091042.
5
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months.辉瑞-BioNTech 信使核糖核酸新冠病毒疫苗 6 个月的安全性和有效性
N Engl J Med. 2021 Nov 4;385(19):1761-1773. doi: 10.1056/NEJMoa2110345. Epub 2021 Sep 15.
6
Decline of antibody titres 3 months after two doses of BNT162b2 in non-immunocompromised adults.非免疫功能低下的成年人接种两剂 BNT162b2 后 3 个月抗体滴度下降。
Clin Microbiol Infect. 2022 Jan;28(1):139.e1-139.e4. doi: 10.1016/j.cmi.2021.08.023. Epub 2021 Sep 9.
7
Antibody responses to BNT162b2 mRNA COVID-19 vaccine and their predictors among healthcare workers in a tertiary referral hospital in Japan.日本一家三级转诊医院医护人员对 BNT162b2 mRNA COVID-19 疫苗的抗体反应及其预测因素。
Clin Microbiol Infect. 2021 Dec;27(12):1861.e1-1861.e5. doi: 10.1016/j.cmi.2021.07.042. Epub 2021 Aug 8.
8
Covid-19 Breakthrough Infections in Vaccinated Health Care Workers.新冠疫苗突破性感染在已接种疫苗的医护人员中发生。
N Engl J Med. 2021 Oct 14;385(16):1474-1484. doi: 10.1056/NEJMoa2109072. Epub 2021 Jul 28.
9
Antibody titres decline 3-month post-vaccination with BNT162b2.接种 BNT162b2 疫苗 3 个月后,抗体滴度下降。
Emerg Microbes Infect. 2021 Dec;10(1):1495-1498. doi: 10.1080/22221751.2021.1953403.
10
Frequency, risk factors, and outcomes of hospital readmissions of COVID-19 patients.COVID-19 患者住院再入院的频率、风险因素和结果。
Sci Rep. 2021 Jul 2;11(1):13733. doi: 10.1038/s41598-021-93076-0.